{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T22:01:06Z","timestamp":1780696866889,"version":"3.54.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T00:00:00Z","timestamp":1748131200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T00:00:00Z","timestamp":1748131200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Microbiol"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s00284-025-04233-x","type":"journal-article","created":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T12:13:35Z","timestamp":1748175215000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Exploring Escherichia coli EGY Type II L-Asparaginase Variant of Unique Glutaminase Activity: Cloning, Expression, Biochemical Characterization, and Molecular Docking Analysis"],"prefix":"10.1007","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-3027-4647","authenticated-orcid":false,"given":"Rawan","family":"Alshamy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nehal","family":"Aly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nefertiti","family":"El-Nikhely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisham A.","family":"Nematalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Elkewedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hesham","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,25]]},"reference":[{"issue":"1","key":"4233_CR1","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.drudis.2021.09.004","volume":"27","author":"JN Hennigan","year":"2022","unstructured":"Hennigan JN, Lynch MD (2022) The past, present, and future of enzyme-based therapies. Drug Discovery Today 27(1):117\u2013133. https:\/\/doi.org\/10.1016\/j.drudis.2021.09.004","journal-title":"Drug Discovery Today"},{"key":"4233_CR2","doi-asserted-by":"publisher","first-page":"15220","DOI":"10.3390\/ijms242015220","volume":"24","author":"AN Shishparenok","year":"2023","unstructured":"Shishparenok AN, Gladilina YA, Zhdanov DD (2023) Engineering and expression strategies for optimization of L-asparaginase development and production. Int J Mol Sci 24:15220. https:\/\/doi.org\/10.3390\/ijms242015220","journal-title":"Int J Mol Sci"},{"key":"4233_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10989-021-10312-x","volume":"28","author":"A Vimal","year":"2022","unstructured":"Vimal A, Kumar A (2022) l-asparaginase: need for an expedition from an enzymatic molecule to antimicrobial drug. Int J Pept Res Ther 28:1\u20135. https:\/\/doi.org\/10.1007\/s10989-021-10312-x","journal-title":"Int J Pept Res Ther"},{"key":"4233_CR4","doi-asserted-by":"publisher","first-page":"100908","DOI":"10.1016\/j.blre.2021.100908","volume":"53","author":"D Douer","year":"2022","unstructured":"Douer D, G\u00f6kbuget N, Stock W, Boissel N (2022) Optimizing use of L-asparaginase-based treatment of adults with acute lymphoblastic leukemia. Blood Rev 53:100908. https:\/\/doi.org\/10.1016\/j.blre.2021.100908","journal-title":"Blood Rev"},{"issue":"6","key":"4233_CR5","doi-asserted-by":"publisher","first-page":"3861","DOI":"10.18632\/oncotarget.2869","volume":"6","author":"P Song","year":"2015","unstructured":"Song P, Ye L, Fan J, Li Y, Zeng X, Wang Z, Wang S, Zhang G, Yang P, Cao Z, Ju D (2015) Asparaginase induces apoptosis and cytoprotective autophagy in chronic myeloid leukemia cells. Oncotarget 6(6):3861\u20133873. https:\/\/doi.org\/10.18632\/oncotarget.2869","journal-title":"Oncotarget"},{"key":"4233_CR6","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1182\/blood.2019004090","volume":"136","author":"A Watanabe","year":"2022","unstructured":"Watanabe A, Miyake K, Nordlund J, Syv\u00e4nen AC, van der Weyden L, Honda H, Yamasaki N, Nagamachi A, Inaba T, Ikawa T, Urayama KY, Kiyokawa N, Ohara A, Kimura S, Kubota Y, Takita J, Goto H, Sakaguchi K, Minegishi M, Iwamoto S, Inukai T (2022) Association of aberrant ASNS imprinting with asparaginase sensitivity and chromosomal abnormality in childhood BCP-ALL. Blood 136:2319\u20132333. https:\/\/doi.org\/10.1182\/blood.2019004090","journal-title":"Blood"},{"key":"4233_CR7","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1158\/0008-5472.CAN-17-2106","volume":"78","author":"HA Nguyen","year":"2018","unstructured":"Nguyen HA, Su Y, Zhang JY, Antanasijevic A, Caffrey M, Schalk AM, Liu L, Rondelli D, Oh A, Mahmud DL, Bosland MC, Kajdacsy-Balla A, Peirs S, Lammens T, Mondelaers V, De Moerloose B, Goossens S, Schlicht MJ, Kabirov KK, Lyubimov AV, Merrill BJ, Saunthararajah Y, Van Vlierberghe P, Lavie A (2018) A novel l-Asparaginase with low l-Glutaminase coactivity is highly efficacious against both T- and B-cell acute lymphoblastic leukemias in vivo. Cancer Res 78:1549\u20131560. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-2106","journal-title":"Cancer Res"},{"issue":"5","key":"4233_CR8","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1182\/blood-2010-07-298422","volume":"117","author":"MN Offman","year":"2011","unstructured":"Offman MN, Krol M, Patel N, Krishnan S, Liu J, Saha V, Bates PA (2011) Rational engineering of L-asparaginase reveals importance of dual activity for cancer cell toxicity. Blood, J Am Soc Hematol 117(5):1614\u20131621. https:\/\/doi.org\/10.1182\/blood-2010-07-298422","journal-title":"Blood, J Am Soc Hematol"},{"issue":"44","key":"4233_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.22108\/bjm.2021.129050.1393","volume":"11","author":"N Gholami","year":"2022","unstructured":"Gholami N, Ebrahimipour GH, Yaghoubi Avini M (2022) A study of the optimization of anti-tumor L-Asparaginase production using bacillus subtilis isolated from the soil of east Azerbaijan province. J Microb Biol 11(44):1\u201312. https:\/\/doi.org\/10.22108\/bjm.2021.129050.1393","journal-title":"J Microb Biol"},{"key":"4233_CR10","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.crbiot.2021.05.006","volume":"3","author":"M Vachher","year":"2021","unstructured":"Vachher M, Sen A, Kapila R, Nigam A (2021) Microbial therapeutic enzymes: a promising area of biopharmaceuticals. Curr Res Biotechnol 3:195\u2013208. https:\/\/doi.org\/10.1016\/j.crbiot.2021.05.006","journal-title":"Curr Res Biotechnol"},{"key":"4233_CR11","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.3389\/fimmu.2018.02213","volume":"9","author":"PP Kar","year":"2018","unstructured":"Kar PP, Srivastava A (2018) Immuno-informatics analysis to identify novel vaccine candidates and design of a multi-epitope based vaccine candidate against theileria parasites. Front Immunol 9:2213. https:\/\/doi.org\/10.3389\/fimmu.2018.02213","journal-title":"Front Immunol"},{"key":"4233_CR12","doi-asserted-by":"publisher","first-page":"3791","DOI":"10.2174\/1381612824666181106094133","volume":"24","author":"S Kaliamurthi","year":"2018","unstructured":"Kaliamurthi S, Selvaraj G, Junaid M, Khan A, Gu K, Wei D-Q (2018) Cancer immunoinformatics: a promising era in the development of peptide vaccines for human papillomavirus-induced cervical cancer. Curr Pharm Des 24:3791\u20133817. https:\/\/doi.org\/10.2174\/1381612824666181106094133","journal-title":"Curr Pharm Des"},{"key":"4233_CR13","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1006\/abio.1976.9999","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248\u2013254. https:\/\/doi.org\/10.1006\/abio.1976.9999","journal-title":"Anal Biochem"},{"key":"4233_CR14","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1099\/00221287-76-1-85","volume":"76","author":"A Imada","year":"1973","unstructured":"Imada A, Igarasi S, Nakahama K, Isono M (1973) Asparaginase and glutaminase activities of micro-organisms. J Gen Microbiol 76:85\u201399. https:\/\/doi.org\/10.1099\/00221287-76-1-85","journal-title":"J Gen Microbiol"},{"key":"4233_CR15","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/978-3-319-27951-0_21","volume-title":"Gene expression systems in fungi: advancements and applications","author":"E Gomes","year":"2016","unstructured":"Gomes E, de Souza AR, Orjuela GL, Da Silva R, de Oliveira TB, Rodrigues A (2016) Applications and benefits of thermophilic microorganisms and their enzymes for industrial biotechnology. In: Schmoll M, Dattenb\u00f6ck C (eds) Gene expression systems in fungi: advancements and applications. Springer International Publishing, Cham, pp 459\u2013492"},{"issue":"2","key":"4233_CR16","doi-asserted-by":"publisher","first-page":"113568","DOI":"10.1016\/j.yexcr.2023.113568","volume":"426","author":"J Blachier","year":"2023","unstructured":"Blachier J, Cleret A, Guerin N, Gil C, Fanjat JM, Tavernier F, Vidault L, Gallix F, Rama N, Rossignol R, Piedrahita D (2023) L-asparaginase anti-tumor activity in pancreatic cancer is dependent on its glutaminase activity and resistance is mediated by glutamine synthetase. Experimental Cell Res 426(2):113568. https:\/\/doi.org\/10.1016\/j.yexcr.2023.113568","journal-title":"Experimental Cell Res"},{"key":"4233_CR17","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3390\/ph14010072","volume":"14","author":"MT Kuo","year":"2021","unstructured":"Kuo MT, Chen HHW, Feun LG, Savaraj N (2021) Targeting the proline-glutamine-asparagine-arginine metabolic axis in amino acid starvation cancer therapy. Pharmaceuticals 14:72. https:\/\/doi.org\/10.3390\/ph14010072","journal-title":"Pharmaceuticals"},{"key":"4233_CR18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.4062\/biomolther.2017.178","volume":"26","author":"YK Choi","year":"2018","unstructured":"Choi YK, Park KG (2018) Targeting glutamine metabolism for cancer treatment. Biomol & Therapeutics 26:19\u201328. https:\/\/doi.org\/10.4062\/biomolther.2017.178","journal-title":"Biomol & Therapeutics"},{"issue":"23","key":"4233_CR19","doi-asserted-by":"publisher","first-page":"3596","DOI":"10.1182\/blood-2013-10-535112","volume":"123","author":"WK Chan","year":"2014","unstructured":"Chan WK, Lorenzi PL, Anishkin A, Purwaha P, Rogers DM, Sukharev S, Rempe SB, Weinstein JN (2014) The glutaminase activity of L-asparaginase is not required for anticancer activity against ASNS-negative cells. Blood 123(23):3596\u20133606. https:\/\/doi.org\/10.1182\/blood-2013-10-535112","journal-title":"Blood"},{"key":"4233_CR20","doi-asserted-by":"publisher","first-page":"217404","DOI":"10.1016\/j.canlet.2024.217404","volume":"611","author":"M Van Trimpont","year":"2025","unstructured":"Van Trimpont M, Schalk AM, Hofkens K, Peeters E, T\u2019Sas S, Vandemeulebroecke K, Su Y, De Loera A, Garcia A, Chen H, Lammens T, Van Vlierberghe P, Goossens S, Lavie A (2025) A human-like glutaminase-free asparaginase is highly efficacious in ASNSlow leukemia and solid cancer mouse xenograft models. Cancer Lett 611:217404. https:\/\/doi.org\/10.1016\/j.canlet.2024.217404","journal-title":"Cancer Lett"},{"key":"4233_CR21","doi-asserted-by":"publisher","first-page":"1269282","DOI":"10.3389\/fmicb.2024.1269282","volume":"15","author":"K Tsegaye","year":"2024","unstructured":"Tsegaye K, Tsehai BA, Getie B (2024) Desirable L-asparaginases for treating cancer and current research trends. Front Microbiol 15:1269282. https:\/\/doi.org\/10.3389\/fmicb.2024.1269282","journal-title":"Front Microbiol"},{"key":"4233_CR22","doi-asserted-by":"publisher","first-page":"102613","DOI":"10.1016\/j.nano.2022.102613","volume":"47","author":"CA Das","year":"2023","unstructured":"Das CA, Kumar VG, Dhas TS, Karthick V, Kumar CV (2023) Nanomaterials in anticancer applications and their mechanism of action-A review. Nanomed Nanotechnol Biol Med 47:102613. https:\/\/doi.org\/10.1016\/j.nano.2022.102613","journal-title":"Nanomed Nanotechnol Biol Med"},{"key":"4233_CR23","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1107\/S2052252521006011","volume":"8","author":"JI Loch","year":"2021","unstructured":"Loch JI, Jaskolski M (2021) Structural and biophysical aspects of l-asparaginases: a growing family with amazing diversity. IUCrJ 8:514\u2013531. https:\/\/doi.org\/10.1107\/S2052252521006011","journal-title":"IUCrJ"},{"key":"4233_CR24","doi-asserted-by":"publisher","first-page":"15797","DOI":"10.1038\/s41598-022-19689-1","volume":"12","author":"A Zielezinski","year":"2022","unstructured":"Zielezinski A, Loch JI, Karlowski WM, Jaskolski M (2022) Massive annotation of bacterial L-asparaginases reveals their puzzling distribution and frequent gene transfer events. Sci Rep 12:15797. https:\/\/doi.org\/10.1038\/s41598-022-19689-1","journal-title":"Sci Rep"},{"key":"4233_CR25","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1021\/acs.biochem.5b01351","volume":"55","author":"HA Nguyen","year":"2016","unstructured":"Nguyen HA, Su Y, Lavie A (2016) Structural insight into substrate selectivity of Erwinia chrysanthemi L-asparaginase. Biochemistry 55:1246\u20131253. https:\/\/doi.org\/10.1021\/acs.biochem.5b01351","journal-title":"Biochemistry"},{"key":"4233_CR26","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1002\/cncr.25489","volume":"117","author":"R Pieters","year":"2011","unstructured":"Pieters R, Hunger SP, Boos J, Rizzari C, Silverman L, Baruchel A, Goekbuget N, Schrappe M, Pui CH (2011) L-asparaginase treatment in acute lymphoblastic leukemia: a focus on Erwinia asparaginase. Cancer 117:238\u2013249. https:\/\/doi.org\/10.1002\/cncr.25489","journal-title":"Cancer"},{"key":"4233_CR27","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.biomaterials.2009.09.077","volume":"31","author":"TH Rogers","year":"2010","unstructured":"Rogers TH, Babensee JE (2010) Altered adherent leukocyte profile on biomaterials in Toll-like receptor 4 deficient mice. Biomaterials 31:594\u2013601. https:\/\/doi.org\/10.1016\/j.biomaterials.2009.09.077","journal-title":"Biomaterials"},{"key":"4233_CR28","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1002\/pro.3709","volume":"28","author":"J Lubkowski","year":"2019","unstructured":"Lubkowski J, Wlodawer A (2019) Geometric considerations support the double-displacement catalytic mechanism of l-asparaginase, protein science\u202f: a publication of the protein. Society 28:1850\u20131864. https:\/\/doi.org\/10.1002\/pro.3709","journal-title":"Society"},{"key":"4233_CR29","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1517\/14656566.8.12.1977","volume":"8","author":"CH Fu","year":"2007","unstructured":"Fu CH, Sakamoto KM (2007) PEG-asparaginase. Expert Opin Pharmacother 8:1977\u20131984. https:\/\/doi.org\/10.1517\/14656566.8.12.1977","journal-title":"Expert Opin Pharmacother"},{"key":"4233_CR30","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.2217\/fon.14.138","volume":"10","author":"MJ Burke","year":"2014","unstructured":"Burke MJ (2014) How to manage asparaginase hypersensitivity in acute lymphoblastic leukemia. Future Oncol 10:2615\u20132627. https:\/\/doi.org\/10.2217\/fon.14.138","journal-title":"Future Oncol"},{"issue":"3","key":"4233_CR31","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/pbc.26884.10.1002\/pbc.26884","volume":"65","author":"CH Pui","year":"2017","unstructured":"Pui CH, Liu Y, Relling M (2017) How to solve the problem of hypersensitivity to asparaginase? Pediatr Blood Cancer 65(3):10\u20131002. https:\/\/doi.org\/10.1002\/pbc.26884.10.1002\/pbc.26884","journal-title":"Pediatr Blood Cancer"},{"key":"4233_CR32","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/00043426-200404000-00002","volume":"26","author":"EH Panosyan","year":"2004","unstructured":"Panosyan EH, Seibel NL, Martin-Aragon S, Gaynon PS, Avramis IA, Sather H, Franklin J, Nachman J, Ettinger LJ, La M, Steinherz P, Cohen LJ, Siegel SE, Avramis VI (2004) Children\u2019s cancer group study CCG-1961, Asparaginase antibody and asparaginase activity in children with higher-risk acute lymphoblastic leukemia: children\u2019s Cancer Group Study CCG-1961. J Pediatr Hematol Oncol 26:217\u2013226. https:\/\/doi.org\/10.1097\/00043426-200404000-00002","journal-title":"J Pediatr Hematol Oncol"},{"key":"4233_CR33","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1080\/10428190701292049","volume":"48","author":"B Zalewska-Szewczyk","year":"2007","unstructured":"Zalewska-Szewczyk B, Andrzejewski W, M\u0142ynarski W, Jedrychowska-Da\u0144ska K, Witas H, Bodalski J (2007) The anti-asparagines antibodies correlate with L-asparagines activity and may affect clinical outcome of childhood acute lymphoblastic leukemia. Leuk Lymphoma 48:931\u2013936. https:\/\/doi.org\/10.1080\/10428190701292049","journal-title":"Leuk Lymphoma"},{"key":"4233_CR34","doi-asserted-by":"publisher","first-page":"367","DOI":"10.2165\/00003088-200544040-00003","volume":"44","author":"VI Avramis","year":"2005","unstructured":"Avramis VI, Panosyan EH (2005) Pharmacokinetic\/pharmacodynamic relationships of asparaginase formulations: the past, the present and recommendations for the future. Clin Pharmacokinet 44:367\u2013393. https:\/\/doi.org\/10.2165\/00003088-200544040-00003","journal-title":"Clin Pharmacokinet"},{"key":"4233_CR35","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1203\/00006450-198519040-00017","volume":"19","author":"U Fabry","year":"1985","unstructured":"Fabry U, K\u00f6rholz D, J\u00fcrgens H, G\u00f6bel U, Wahn V (1985) Anaphylaxis to L-asparaginase during treatment for acute lymphoblastic leukemia in children-evidence of a complement-mediated mechanism. Pediatr Res 19:400\u2013408. https:\/\/doi.org\/10.1203\/00006450-198519040-00017","journal-title":"Pediatr Res"},{"key":"4233_CR36","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3109\/10428194.2010.537796","volume":"52","author":"H van den Berg","year":"2011","unstructured":"van den Berg H (2011) Asparaginase revisited. Leuk Lymphoma 52:168\u2013178. https:\/\/doi.org\/10.3109\/10428194.2010.537796","journal-title":"Leuk Lymphoma"},{"key":"4233_CR37","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1200\/JCO.1993.11.9.1780","volume":"11","author":"BL Asselin","year":"1993","unstructured":"Asselin BL, Whitin JC, Coppola DJ, Rupp IP, Sallan SE, Cohen HJ (1993) Comparative pharmacokinetic studies of three asparaginase preparations. J Clinical Oncol\u202f: Off J Am Soc Clinical Oncol 11:1780\u20131786. https:\/\/doi.org\/10.1200\/JCO.1993.11.9.1780","journal-title":"J Clinical Oncol : Off J Am Soc Clinical Oncol"},{"key":"4233_CR38","doi-asserted-by":"publisher","first-page":"11782","DOI":"10.1073\/pnas.1209292109","volume":"109","author":"W Liu","year":"2012","unstructured":"Liu W, Onda M, Lee B, Kreitman RJ, Hassan R, Xiang L, Pastan I (2012) Recombinant immunotoxin engineered for low immunogenicity and antigenicity by identifying and silencing human B-cell epitopes. Proc Natl Acad Sci USA 109:11782\u201311787. https:\/\/doi.org\/10.1073\/pnas.1209292109","journal-title":"Proc Natl Acad Sci USA"},{"key":"4233_CR39","doi-asserted-by":"publisher","first-page":"8571","DOI":"10.1073\/pnas.1405153111","volume":"111","author":"R Mazor","year":"2014","unstructured":"Mazor R, Eberle JA, Hu X, Vassall AN, Onda M, Beers R, Lee EC, Kreitman RJ, Lee B, Baker D, King C, Hassan R, Benhar I, Pastan I (2014) Recombinant immunotoxin for cancer treatment with low immunogenicity by identification and silencing of human T-cell epitopes. Proc Natl Acad Sci USA 111:8571\u20138576. https:\/\/doi.org\/10.1073\/pnas.1405153111","journal-title":"Proc Natl Acad Sci USA"},{"issue":"21","key":"4233_CR40","doi-asserted-by":"publisher","first-page":"29916","DOI":"10.18632\/oncotarget.9171","volume":"7","author":"R Mazor","year":"2016","unstructured":"Mazor R, Onda M, Park D, Addissie S, Xiang L, Zhang J, Hassan R, Pastan I (2016) Dual B-and T-cell de-immunization of recombinant immunotoxin targeting mesothelin with high cytotoxic activity. Oncotarget 7(21):29916. https:\/\/doi.org\/10.18632\/oncotarget.9171","journal-title":"Oncotarget"},{"key":"4233_CR41","first-page":"332","volume":"10","author":"AS De Groot","year":"2007","unstructured":"De Groot AS, Moise L (2007) Prediction of immunogenicity for therapeutic proteins: state of the art. Curr Opin Drug Discov Devel 10:332\u2013340","journal-title":"Curr Opin Drug Discov Devel"},{"key":"4233_CR42","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.biologicals.2019.03.003","volume":"59","author":"LH Bel\u00e9n","year":"2019","unstructured":"Bel\u00e9n LH, Lissabet JB, de Oliveira Rangel-Yagui C, Effer B, Monteiro G, Pessoa A, Avenda\u00f1o JGF (2019) A structural in silico analysis of the immunogenicity of l-asparaginase from Escherichia coli and Erwinia carotovora. Biologicals 59:47\u201355. https:\/\/doi.org\/10.1016\/j.biologicals.2019.03.003","journal-title":"Biologicals"},{"key":"4233_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s42452-020-2021-z","volume":"2","author":"LH Bel\u00e9n","year":"2020","unstructured":"Bel\u00e9n LH, Beltr\u00e1n Lissabet JF, de Oliveira Rangel-Yagui C, Monteiro G, Pessoa A, Far\u00edas JG (2020) Immunogenicity assessment of fungal l-asparaginases: an in silico approach. SN Appl Sci 2:1\u201310. https:\/\/doi.org\/10.1007\/s42452-020-2021-z","journal-title":"SN Appl Sci"},{"key":"4233_CR44","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.arcmed.2021.01.004","volume":"52","author":"C Chakraborty","year":"2021","unstructured":"Chakraborty C, Sharma AR, Bhattacharya M, Sharma G, Lee SS (2021) Immunoinformatics approach for the identification and characterization of T cell and B cell epitopes towards the peptide-based vaccine against SARS-CoV-2. Arch Med Res 52:362\u2013370. https:\/\/doi.org\/10.1016\/j.arcmed.2021.01.004","journal-title":"Arch Med Res"},{"key":"4233_CR45","doi-asserted-by":"publisher","first-page":"720","DOI":"10.3109\/1040841X.2015.1022505","volume":"42","author":"PR Krishnapura","year":"2016","unstructured":"Krishnapura PR, Belur PD, Subramanya S (2016) A critical review on properties and applications of microbial l-asparaginases. Crit Rev Microbiol 42:720\u2013737. https:\/\/doi.org\/10.3109\/1040841X.2015.1022505","journal-title":"Crit Rev Microbiol"},{"key":"4233_CR46","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1007\/s00203-020-01814-1","volume":"202","author":"F Muneer","year":"2020","unstructured":"Muneer F, Siddique MH, Azeem F, Rasul I, Muzammil S, Zubair M, Afzal M, Nadeem H (2020) Microbial l-asparaginase: purification, characterization and applications. Arch Microbiol 202:967\u2013981. https:\/\/doi.org\/10.1007\/s00203-020-01814-1","journal-title":"Arch Microbiol"},{"key":"4233_CR47","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0734-9750(88)90573-3","volume":"6","author":"OP Ward","year":"1988","unstructured":"Ward OP, Moo-Young M (1988) Thermostable enzymes. Biotechnol Adv 6:39\u201369. https:\/\/doi.org\/10.1016\/0734-9750(88)90573-3","journal-title":"Biotechnol Adv"},{"key":"4233_CR48","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1016\/j.jmb.2015.06.017","volume":"427","author":"A Anishkin","year":"2015","unstructured":"Anishkin A, Vanegas JM, Rogers DM, Lorenzi PL, Chan WK, Purwaha P, Weinstein JN, Sukharev S, Rempe SB (2015) Catalytic role of the substrate defines specificity of therapeutic L-asparaginase. J Mol Biol 427:2867\u20132885. https:\/\/doi.org\/10.1016\/j.jmb.2015.06.017","journal-title":"J Mol Biol"},{"issue":"9","key":"4233_CR49","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.3324\/haematol.2018.206433","volume":"104","author":"C Rizzari","year":"2019","unstructured":"Rizzari C, Lanvers-Kaminsky C, Valsecchi MG, Ballerini A, Matteo C, Gerss J, Wuerthwein G, Silvestri D, Colombini A, Conter V, Biondi A (2019) Asparagine levels in the cerebrospinal fluid of children with acute lymphoblastic leukemia treated with pegylated-asparaginase in the induction phase of the AIEOP-BFM ALL 2009 study. Haematologica 104(9):1812. https:\/\/doi.org\/10.3324\/haematol.2018.206433","journal-title":"Haematologica"}],"container-title":["Current Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-025-04233-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00284-025-04233-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-025-04233-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T02:17:50Z","timestamp":1749867470000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00284-025-04233-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,25]]},"references-count":49,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["4233"],"URL":"https:\/\/doi.org\/10.1007\/s00284-025-04233-x","relation":{},"ISSN":["0343-8651","1432-0991"],"issn-type":[{"value":"0343-8651","type":"print"},{"value":"1432-0991","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,25]]},"assertion":[{"value":"6 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"No human subjects are involved in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All authors read and approved the data for publication.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}],"article-number":"306"}}